Medical Innovation

Patient-Based Pricing: An Answer To The Soaring Cost of Innovation?

Posted on Sep 21, 2012 in Company, Cost/Comparative Effectiveness, Health Technology Assessments, Medical Innovation, Payers: Commercial, Payment Reform, Personalized Medicine, Pharmaceuticals, Pricing, Uncategorized, Value-based pricing

Roche’s investor day on Sept. 5 provided heartening news for breast cancer patients. Executives outlined an array of increasingly targeted therapeutic permutations to combat the tumor, building on its...

Learn More

The Ugly Truth: Pharma’s Poorly Placed to Address Payor Pressures

Posted on Jun 19, 2012 in Cost/Comparative Effectiveness, Health Technology Assessments, Medical Innovation, Payers: Commercial, Payers: Managed Medicaid/Medicare, Payment Reform, Pharmaceuticals, Pricing, Value-based pricing

That was the message from Citi’s healthcare conference held in New York back in February. It’s not a new message, but as with any information that’s vital to a sector’s future, it has...

Learn More